Establishment of cell models for Blau syndrome

Objective To establish a stable and reliable cell models of Blau syndrome (BS)in vitro. Methods RAW264.7, iBMDM and THP-1 cells were used as the research objects and then stimulated by muramyl dipeptide (MDP) or L18-MDP. Meanwhile, positive drugs etanercept (ETN) and GSK583 treatment groups were set...

Full description

Bibliographic Details
Main Author: SONG Hao-xin, YE Cai-ying, ZHU Lei
Format: Article
Language:zho
Published: Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2022-03-01
Series:Jichu yixue yu linchuang
Subjects:
Online Access:http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-3-406.pdf
_version_ 1797365845299560448
author SONG Hao-xin, YE Cai-ying, ZHU Lei
author_facet SONG Hao-xin, YE Cai-ying, ZHU Lei
author_sort SONG Hao-xin, YE Cai-ying, ZHU Lei
collection DOAJ
description Objective To establish a stable and reliable cell models of Blau syndrome (BS)in vitro. Methods RAW264.7, iBMDM and THP-1 cells were used as the research objects and then stimulated by muramyl dipeptide (MDP) or L18-MDP. Meanwhile, positive drugs etanercept (ETN) and GSK583 treatment groups were set to investigate the response of the model to evaluate effectiveness. Cell culture supernatant was collected after 22 h, and the level of tumor necrosis factor-α (TNF-α) was determined by enzyme linked immunosorbent assay (ELISA). Results The secretion of TNF-α from RAW264.7 and iBMDM cells was significantly increased after stimulation by 10 μg/mL MDP(P<0.01), while ETN and GSK583 inhibited the increase of TNF-α induced by MDP(P<0.01). After THP-1 cells were induced into THP-1-Mφ by PMA, 0.2 and 1 μg/mL L18-MDP increased the level of TNF-α in the culture supernatant(P<0.01). When ETN was added along with 0.2 μg/mL L18-MDP, the secretion of TNF-α was significantly inhibited (P<0.01). Conclusions RAW264.7,iBMDM and THP-1 cells may develop good cell models for BS in vitro. The model has the advantages of simplicity, convenience, easy repetition and strong controllability, which lay a foundation for further research on the pathogenesis of BS and screening and evaluation of therapeutic drugs.
first_indexed 2024-03-08T16:55:43Z
format Article
id doaj.art-4606e4f281dc43ceba9783c2d26f03d7
institution Directory Open Access Journal
issn 1001-6325
language zho
last_indexed 2024-03-08T16:55:43Z
publishDate 2022-03-01
publisher Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
record_format Article
series Jichu yixue yu linchuang
spelling doaj.art-4606e4f281dc43ceba9783c2d26f03d72024-01-05T02:34:23ZzhoInstitute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.Jichu yixue yu linchuang1001-63252022-03-0142340641010.16352/j.issn.1001-6325.2022.03.036Establishment of cell models for Blau syndromeSONG Hao-xin, YE Cai-ying, ZHU Lei0Department of Pharmacology, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC, Beijing 100005, ChinaObjective To establish a stable and reliable cell models of Blau syndrome (BS)in vitro. Methods RAW264.7, iBMDM and THP-1 cells were used as the research objects and then stimulated by muramyl dipeptide (MDP) or L18-MDP. Meanwhile, positive drugs etanercept (ETN) and GSK583 treatment groups were set to investigate the response of the model to evaluate effectiveness. Cell culture supernatant was collected after 22 h, and the level of tumor necrosis factor-α (TNF-α) was determined by enzyme linked immunosorbent assay (ELISA). Results The secretion of TNF-α from RAW264.7 and iBMDM cells was significantly increased after stimulation by 10 μg/mL MDP(P<0.01), while ETN and GSK583 inhibited the increase of TNF-α induced by MDP(P<0.01). After THP-1 cells were induced into THP-1-Mφ by PMA, 0.2 and 1 μg/mL L18-MDP increased the level of TNF-α in the culture supernatant(P<0.01). When ETN was added along with 0.2 μg/mL L18-MDP, the secretion of TNF-α was significantly inhibited (P<0.01). Conclusions RAW264.7,iBMDM and THP-1 cells may develop good cell models for BS in vitro. The model has the advantages of simplicity, convenience, easy repetition and strong controllability, which lay a foundation for further research on the pathogenesis of BS and screening and evaluation of therapeutic drugs.http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-3-406.pdfblau syndrome|cell model|muramyl dipeptide(mdp)|tumor necrosis factor-α
spellingShingle SONG Hao-xin, YE Cai-ying, ZHU Lei
Establishment of cell models for Blau syndrome
Jichu yixue yu linchuang
blau syndrome|cell model|muramyl dipeptide(mdp)|tumor necrosis factor-α
title Establishment of cell models for Blau syndrome
title_full Establishment of cell models for Blau syndrome
title_fullStr Establishment of cell models for Blau syndrome
title_full_unstemmed Establishment of cell models for Blau syndrome
title_short Establishment of cell models for Blau syndrome
title_sort establishment of cell models for blau syndrome
topic blau syndrome|cell model|muramyl dipeptide(mdp)|tumor necrosis factor-α
url http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-3-406.pdf
work_keys_str_mv AT songhaoxinyecaiyingzhulei establishmentofcellmodelsforblausyndrome